<DOC>
	<DOCNO>NCT00033176</DOCNO>
	<brief_summary>The purpose study determine immunomodulatory antiviral effect glutathione-restoring dithiol , alpha lipoic acid ( ALA ) HIV-infected person unresponsive highly active antiretroviral treatment ( HAART ) .</brief_summary>
	<brief_title>Immune Restoration Lipoic Acid AIDS</brief_title>
	<detailed_description>AIDS characterize infection HIV lead collapse immune system . Although highly active antiretroviral therapy ( HAART ) contribute significantly lower morbidity mortality AIDS , antiretroviral drug fully restore immune system patient often fail multi-drug treatment . Hence , need alternative/complementary medicine ( CAM ) restore immune system ravage HIV/AIDS . To address need , investigator form multidisciplinary collaboration evaluate demonstrate utility natural immune-based modulators ethnically diverse patient HIV/AIDS . The long-term goal proposal develop CAM therapy facilitate immune reconstitution HIV eradication follow cessation antiretroviral treatment concurrent continue antiretroviral treatment . It base premise widespread deficiency glutathione ( GSH ) , vital lymphocyte function , patient HIV/AIDS . The propose project study immunomodulatory antiretroviral effect dietary antioxidant , alpha-lipoic acid ( ALA ) , know efficiently boost systemic GSH . In study , HIV-infected adult unresponsive HAART ( i.e . persistent CD4+ count &gt; 50 cells/mm3 , viral load &gt; 10,000 copies/cc ) randomize treatment control arm . The treatment group give 300 mg ALA thrice daily 6 month control group receive inert placebo . Studies perform baseline 2,4 , 6 month include estimation CD4+ count , HIV RNA , T-cell reactivity vitro whole blood GSH level . Significance change baseline parameter analyze t-tests . The propose research show whether GSH augmentation ALA increase CD4+ cell number T cell function reduce viral load subject unresponsive antiretroviral therapy .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>HIVpositive status HAART nonresponsiveness define 1 ) previous experience least 2 different protease inhibitor plus nucleoside analog ; 2 ) viral load &gt; 10,000 copies/cc CD4+ cell count &gt; 50 x 1000 cells/liter time enrollment Diabetic patient Pregnant woman Asthmatic patient Severely thiaminedeficient person ( e.g . alcoholic polyneuritis ) History supplement excessive amount Nacetylcysteine , glutathione antioxidant supplement , 2 month prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>complementary therapy</keyword>
	<keyword>Immune restoration</keyword>
	<keyword>HIV infection</keyword>
	<keyword>AIDS</keyword>
	<keyword>HAART non-responsiveness</keyword>
	<keyword>glutathione restoration</keyword>
	<keyword>lipoic acid</keyword>
	<keyword>dithiol</keyword>
</DOC>